BG27374A3 - Method of obtaining ergoline structure - Google Patents

Method of obtaining ergoline structure

Info

Publication number
BG27374A3
BG27374A3 BG7530088A BG3008875A BG27374A3 BG 27374 A3 BG27374 A3 BG 27374A3 BG 7530088 A BG7530088 A BG 7530088A BG 3008875 A BG3008875 A BG 3008875A BG 27374 A3 BG27374 A3 BG 27374A3
Authority
BG
Bulgaria
Prior art keywords
obtaining
ergoline
ergoline structure
obtaining ergoline
Prior art date
Application number
BG7530088A
Other languages
Bulgarian (bg)
English (en)
Inventor
Magde
Borsi
Csanyi
Pik
Wolf
Original Assignee
Richter Gedeon Vegyeszeti Gyar Rt,Hu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar Rt,Hu filed Critical Richter Gedeon Vegyeszeti Gyar Rt,Hu
Publication of BG27374A3 publication Critical patent/BG27374A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG7530088A 1974-05-28 1975-05-26 Method of obtaining ergoline structure BG27374A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUGO1272A HU169073B (nl) 1974-05-28 1974-05-28

Publications (1)

Publication Number Publication Date
BG27374A3 true BG27374A3 (en) 1979-10-12

Family

ID=10996767

Family Applications (1)

Application Number Title Priority Date Filing Date
BG7530088A BG27374A3 (en) 1974-05-28 1975-05-26 Method of obtaining ergoline structure

Country Status (21)

Country Link
US (1) US4005089A (nl)
JP (1) JPS5218718B2 (nl)
AT (1) AT346501B (nl)
BE (1) BE829518A (nl)
BG (1) BG27374A3 (nl)
CA (1) CA1051878A (nl)
CS (1) CS194227B2 (nl)
DD (1) DD121639A5 (nl)
DE (1) DE2523743A1 (nl)
DK (1) DK143801C (nl)
ES (1) ES437994A1 (nl)
FI (1) FI61897C (nl)
FR (1) FR2272671B1 (nl)
GB (1) GB1474337A (nl)
HU (1) HU169073B (nl)
IL (1) IL47361A (nl)
NL (1) NL7506276A (nl)
PL (1) PL98944B1 (nl)
SE (1) SE419548B (nl)
SU (1) SU625612A3 (nl)
YU (1) YU135575A (nl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064249A (en) * 1974-05-28 1977-12-20 Richter Gedeon Vegyeszeti Gyar Rt. Compounds with ergoline skeleton
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
HU172479B (hu) * 1976-03-09 1978-09-28 Gyogyszerkutato Intezet Sposob poluchenija novykh soedinenij s ehrgolenovymi i
JPS577172Y2 (nl) * 1977-03-17 1982-02-10
JPS582957U (ja) * 1981-06-30 1983-01-10 松下電子工業株式会社 高圧ナトリウムランプ
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
DD238051A1 (de) * 1985-06-10 1986-08-06 Dresden Arzneimittel Verfahren zur herstellung neuer lysergsaeureamide
US8710092B2 (en) * 2009-12-23 2014-04-29 Map Pharmaceuticals, Inc. Substituted indolo 4,3 FG quinolines useful for treating migraine
BR112013033339A2 (pt) 2011-06-23 2016-08-16 Map Pharmaceuticals Inc análogos de fluorergolina
WO2013095707A1 (en) 2011-12-19 2013-06-27 Map Pharmaceuticals, Inc. Novel iso-ergoline derivatives
CA2859175A1 (en) 2011-12-21 2013-06-27 Map Pharmaceuticals, Inc. Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
CN107428745A (zh) * 2015-01-20 2017-12-01 Xoc制药股份有限公司 麦角灵化合物及其用途
BR112019025420A2 (pt) 2017-06-01 2020-06-16 Xoc Pharmaceuticals, Inc. Compostos policíclicos e usos destes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533699A (en) * 1950-12-12 Amines containing the king system
US2673850A (en) * 1951-07-28 1954-03-30 Sandoz Ag Piperazides of the lysergic acid series
US2946796A (en) * 1958-10-15 1960-07-26 Grace W R & Co Salts of ergot alkaloids
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
SE396753B (sv) * 1970-05-18 1977-10-03 Richter Gedeon Vegyeszet Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
US3901893A (en) * 1970-05-18 1975-08-26 Richter Gedeon Vegyeszet New dihydro-lysergic acid derivative
IL41409A (en) * 1972-02-04 1977-04-29 Richter Gedeon Vegyeszet Lysergic acid amides and process for their preparation

Also Published As

Publication number Publication date
AT346501B (de) 1978-11-10
FI61897C (fi) 1982-10-11
DK235175A (da) 1975-11-29
GB1474337A (en) 1977-05-25
SE419548B (sv) 1981-08-10
IL47361A (en) 1979-11-30
DD121639A5 (nl) 1976-08-12
YU135575A (en) 1982-06-30
FI61897B (fi) 1982-06-30
ES437994A1 (es) 1977-01-16
PL98944B1 (pl) 1978-05-31
JPS5218718B2 (nl) 1977-05-24
IL47361A0 (en) 1975-07-28
ATA386375A (de) 1978-03-15
DK143801C (da) 1982-03-22
CA1051878A (en) 1979-04-03
HU169073B (nl) 1976-09-28
JPS516998A (nl) 1976-01-20
FR2272671B1 (nl) 1978-10-06
AU8142575A (en) 1976-11-25
SU625612A3 (ru) 1978-09-25
FR2272671A1 (nl) 1975-12-26
US4005089A (en) 1977-01-25
SE7505974L (sv) 1975-12-01
CS194227B2 (en) 1979-11-30
NL7506276A (nl) 1975-12-02
DK143801B (da) 1981-10-12
FI751537A (nl) 1975-11-29
DE2523743A1 (de) 1975-12-18
BE829518A (fr) 1975-09-15

Similar Documents

Publication Publication Date Title
BG24815A3 (en) Method of obtaining substituted purines
BG27916A3 (en) Method of obtaining of antibiotic tienamyzin
JPS53101385A (en) Method of producing phenyllpyrimidine
BG27744A3 (en) Method of obtaining of hynazolin derivatives
CS188985B2 (en) Method of producing aryl-1-azolylmethanes
BG24812A3 (en) Method of obtaining 8-thiomethylergolins
BG31949A3 (en) Method for obtaining derivatives of phenyl- 2- indol
BG31223A3 (en) Method for obtaining of tertiarj olephines
BG27374A3 (en) Method of obtaining ergoline structure
BG24542A3 (en) Method of preparing carbonylaldiminomethanphosphonates
CS191882B2 (en) Method of preparing 7-methoxy-6-thia-tetracycline
BG24807A3 (en) Method of obtaining pyridobenzodiazepinones
BG29427A3 (en) Method for obtaining of l- 6- dioxy- 5- hudroxytetracycline
CS188938B2 (en) Method of producing xanthene-9-spiro-4-piperidines
BG27915A3 (en) Method of obtaining of moenomyzin
SU677666A3 (en) Method of producing 7l-or extradiols
CS189635B2 (en) Method of producing bromderivatives of 4-imido-thioazetidin-2-one
BG33288A3 (en) Method for obtaining of 6- methyl- 8 (substituated)- methylergolin
BG24541A3 (en) Method of obtaining indole alkaloids
CS182298B2 (en) Method of producing substituted benzendisulphon-amides
BG30776A3 (en) Method for obtaining of eburnamenine derivatives
JPS51125089A (en) Preparation method of piperazinopyrimidine derivatives
BG31072A4 (en) Method for obtaining of sulphinylazetidinon
BG24821A3 (en) Method of obtaining 2-desoxystreptamine aminoglycosides
BG27376A3 (en) Method of obtaining of ureidesubstiputed cefalosporines